Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
152 hedge funds and large institutions have $1.05B invested in Immunogen Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 22 closing their positions.
41% more capital invested
Capital invested by funds: $746M → $1.05B (+$307M)
21% more call options, than puts
Call options by funds: $2.52M | Put options by funds: $2.08M
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
4% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 46
1% more funds holding
Funds holding: 151 → 152 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$30.8M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$11.1M |
| 3 |
PA
Pinnacle Associates
New York
|
+$6.72M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.66M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$18.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.5M |
| 3 |
State Street
Boston,
Massachusetts
|
-$7.46M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.69M |
| 5 |
Renaissance Technologies
New York
|
-$4.37M |
IMGN Hedge Fund Activity: Q4 2015 in Review
152 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2015, worth a combined $1.05B — up 41% from $746M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new IMGN positions and 22 closed out — a net gain of 1 holder — while 48 added to existing stakes and 46 trimmed.
The largest buyer was OrbiMed, adding an estimated $30.8M. The largest seller was Millennium Management, cutting an estimated $18.8M.
- 152 institutional investors held Immunogen Inc (IMGN) as of Q4 2015, up from 151 in Q3 2015.
- Funds reported $1.05B of Immunogen Inc stock for Q4 2015, up 41% quarter-over-quarter.
- 23 funds opened new Immunogen Inc positions in Q4 2015 and 22 closed out, a net change of +1 holder.
- The largest Immunogen Inc buyer in Q4 2015 was OrbiMed, an estimated $30.8M added.
- The largest Immunogen Inc seller in Q4 2015 was Millennium Management, an estimated $18.8M sold.
Based on aggregated 13F filings for Q4 2015.